Preston Klassen, President & CEO: Metacrine MTCR Sell · Filed 23/01/27

Trade details

Type: Insider sale
Amount: $156,048.05
Shares · price: 380,605 sh · $0.41 a share
Held after: 541,905 sh
Stock: Metacrine MTCR
Person: Preston KlassenPresident & CEO
Trade date: 23/01/26
Filed: 23/01/27
Days to filing: 1 days

Sold 41.3% of holdings

Share of holding sold: 41.3%

Metacrine trades, last 26 weeks

What else happened in Metacrine around then

Filed or reported within 30 days of the trade day · 22/12/27~23/02/25

Preston Klassen's recent trades

Preston KlassenPresident & Head of R & D
BuyRegulus Therapeutics
Buy
Regulus Therapeutics
RGLS
$95.9K
12,000 sh
$95.9K
Filed 25/06/04
Traded 25/06/03
Preston KlassenPresident & Head of R & D
Sell10b5-1 planRegulus Therapeutics
Sell10b5-1 plan
Regulus Therapeutics
RGLS
$39.6K
31,445 sh
$39.6K
Filed 25/01/15
Traded 25/01/13